Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 2435 | 16.15 |
09:34 ET | 100 | 16.265 |
09:36 ET | 100 | 16.1501 |
09:38 ET | 100 | 16.4 |
09:48 ET | 100 | 16.19 |
09:50 ET | 100 | 16.19 |
09:54 ET | 1609 | 16.13 |
09:56 ET | 500 | 16.19 |
09:57 ET | 200 | 16.19 |
09:59 ET | 138 | 16.25 |
10:01 ET | 200 | 16.23 |
10:03 ET | 104 | 16.16 |
10:06 ET | 100 | 16.11 |
10:10 ET | 100 | 16.08 |
10:12 ET | 411 | 16.13 |
10:14 ET | 100 | 16.14 |
10:15 ET | 100 | 16.18 |
10:17 ET | 400 | 16.08 |
10:19 ET | 258 | 16.11 |
10:21 ET | 100 | 16.1812 |
10:24 ET | 1016 | 16.18 |
10:26 ET | 445 | 16.12 |
10:28 ET | 200 | 16.095 |
10:32 ET | 308 | 16.121 |
10:33 ET | 431 | 16.05 |
10:35 ET | 600 | 16.01 |
10:37 ET | 1200 | 15.98 |
10:39 ET | 681 | 16.01 |
10:42 ET | 100 | 15.98 |
10:44 ET | 1422 | 15.95 |
10:46 ET | 390 | 15.85 |
10:55 ET | 400 | 15.84 |
10:57 ET | 400 | 15.85 |
11:00 ET | 888 | 15.81 |
11:02 ET | 1618 | 15.83 |
11:04 ET | 681 | 15.96 |
11:06 ET | 400 | 15.84 |
11:08 ET | 197 | 15.82 |
11:09 ET | 1000 | 15.75 |
11:11 ET | 600 | 15.77 |
11:13 ET | 400 | 15.84 |
11:15 ET | 500 | 15.7749 |
11:18 ET | 841 | 15.8 |
11:20 ET | 2394 | 15.795 |
11:22 ET | 300 | 15.7598 |
11:24 ET | 100 | 15.71 |
11:26 ET | 949 | 15.78 |
11:29 ET | 201 | 15.76 |
11:33 ET | 2087 | 15.665 |
11:42 ET | 400 | 15.63 |
11:44 ET | 100 | 15.63 |
11:45 ET | 202 | 15.63 |
11:47 ET | 1175 | 15.58 |
11:49 ET | 475 | 15.63 |
11:51 ET | 300 | 15.635 |
11:54 ET | 810 | 15.61 |
11:56 ET | 674 | 15.6 |
11:58 ET | 581 | 15.67 |
12:00 ET | 300 | 15.68 |
12:05 ET | 713 | 15.71 |
12:07 ET | 1053 | 15.726 |
12:09 ET | 400 | 15.73 |
12:12 ET | 200 | 15.73 |
12:14 ET | 256 | 15.75 |
12:16 ET | 400 | 15.78 |
12:18 ET | 300 | 15.79 |
12:20 ET | 609 | 15.8 |
12:21 ET | 1060 | 15.795 |
12:25 ET | 619 | 15.805 |
12:30 ET | 200 | 15.78 |
12:32 ET | 231 | 15.77 |
12:34 ET | 400 | 15.75 |
12:36 ET | 400 | 15.75 |
12:38 ET | 1490 | 15.76 |
12:39 ET | 600 | 15.75 |
12:41 ET | 500 | 15.74 |
12:43 ET | 630 | 15.72 |
12:45 ET | 746 | 15.74 |
12:48 ET | 265 | 15.74 |
12:50 ET | 591 | 15.76 |
12:52 ET | 1238 | 15.78 |
12:54 ET | 339 | 15.78 |
12:56 ET | 100 | 15.82 |
12:59 ET | 751 | 15.91 |
01:01 ET | 400 | 15.9 |
01:03 ET | 1200 | 15.8484 |
01:06 ET | 603 | 15.9 |
01:08 ET | 200 | 15.8775 |
01:10 ET | 523 | 15.93 |
01:12 ET | 707 | 15.95 |
01:14 ET | 100 | 15.96 |
01:15 ET | 378 | 15.98 |
01:17 ET | 100 | 15.99 |
01:19 ET | 1070 | 15.995 |
01:21 ET | 572 | 16.03 |
01:24 ET | 546 | 16.04 |
01:26 ET | 621 | 16.07 |
01:28 ET | 834 | 16.06 |
01:30 ET | 200 | 16.05 |
01:32 ET | 100 | 16.05 |
01:37 ET | 1900 | 16.01 |
01:42 ET | 2447 | 16.04 |
01:44 ET | 100 | 15.99 |
01:46 ET | 200 | 16 |
01:48 ET | 514 | 16.01 |
01:50 ET | 1385 | 16.04 |
01:51 ET | 200 | 15.99 |
01:53 ET | 100 | 15.995 |
01:55 ET | 300 | 16.02 |
01:57 ET | 500 | 16.07 |
02:00 ET | 1169 | 16.005 |
02:02 ET | 400 | 15.98 |
02:04 ET | 435 | 15.95 |
02:06 ET | 1031 | 15.93 |
02:08 ET | 206 | 15.89 |
02:09 ET | 100 | 15.94 |
02:11 ET | 2958 | 15.9 |
02:15 ET | 200 | 15.89 |
02:18 ET | 472 | 15.865 |
02:20 ET | 100 | 15.89 |
02:22 ET | 100 | 15.87 |
02:24 ET | 1154 | 15.85 |
02:26 ET | 200 | 15.85 |
02:27 ET | 100 | 15.85 |
02:29 ET | 200 | 15.85 |
02:33 ET | 1039 | 15.85 |
02:36 ET | 1431 | 15.84 |
02:38 ET | 803 | 15.845 |
02:40 ET | 2162 | 15.815 |
02:42 ET | 422 | 15.86 |
02:44 ET | 1074 | 15.9 |
02:45 ET | 735 | 15.9 |
02:47 ET | 200 | 15.9 |
02:49 ET | 100 | 15.89 |
02:51 ET | 456 | 15.9 |
02:54 ET | 946 | 15.84 |
02:56 ET | 1105 | 15.86 |
02:58 ET | 106 | 15.83 |
03:00 ET | 150 | 15.86 |
03:02 ET | 1418 | 15.85 |
03:03 ET | 200 | 15.845 |
03:05 ET | 400 | 15.84 |
03:07 ET | 3939 | 15.87 |
03:09 ET | 2243 | 15.855 |
03:12 ET | 15808 | 15.86 |
03:14 ET | 900 | 15.865 |
03:16 ET | 1024 | 15.82 |
03:20 ET | 643 | 15.8 |
03:21 ET | 200 | 15.84 |
03:23 ET | 600 | 15.85 |
03:25 ET | 1563 | 15.845 |
03:27 ET | 1535 | 15.855 |
03:30 ET | 1026 | 15.85 |
03:32 ET | 3538 | 15.83 |
03:34 ET | 650 | 15.84 |
03:36 ET | 833 | 15.84 |
03:38 ET | 1089 | 15.8 |
03:39 ET | 2865 | 15.795 |
03:41 ET | 1003 | 15.79 |
03:43 ET | 355 | 15.78 |
03:45 ET | 1242 | 15.81 |
03:48 ET | 2963 | 15.83 |
03:50 ET | 5227 | 15.835 |
03:52 ET | 6448 | 15.84 |
03:54 ET | 7071 | 15.77 |
03:56 ET | 4928 | 15.725 |
03:57 ET | 21015 | 15.71 |
03:59 ET | 94880 | 15.72 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.1x | --- |
Ardelyx Inc | 1.3B | -20.1x | --- |
Gyre Therapeutics Inc | 1.2B | -14.5x | --- |
Nurix Therapeutics Inc | 1.5B | -8.0x | --- |
Immatics NV | 1.2B | -12.7x | --- |
Arvinas Inc | 1.7B | -4.6x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.91 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.